BMJ Evidence-Based Medicine: 27 (1)

EBM analysis

Patients’ participation in government-sponsored guidelines in Latin America: a cross-sectional study (5 March, 2021)
Luis Ignacio Garegnani, Nicolás Meza, Pablo Rosón-Rodriguez, Camila Micaela Escobar-Liquitay, Marcelo Arancibia, Eva Madrid, Juan Victor Ariel Franco
Transparency of results reporting for depression treatment studies in ClinicalTrials.gov: a cross-sectional study (30 March, 2021)
Karen B Schmaling, Hailey S Landon, Tiffany B Nguyen, Robert M Kaplan

Effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis: a rapid systematic review (1 October, 2020)
David Jarrom, Lauren Elston, Jennifer Washington, Matthew Prettyjohns, Kimberley Cann, Susan Myles, Peter Groves
Ten years later: a review of the US 2009 institute of medicine report on conflicts of interest and solutions for further reform (11 November, 2020)
Trevor Torgerson, Cole Wayant, Lisa Cosgrove, Elie A Akl, Jake Checketts, Rafael Dal Re, Jennifer Gill, Samir C Grover, Nasim Khan, Rishad Khan, Ana Marušić, Matthew S McCoy, Aaron Mitchell, Vinay Prasad, Matt Vassar

Deaths attributed to the use of medications purchased online (21 December, 2021)
Jeffrey K Aronson, Robin E Ferner, Georgia C Richards